Viyash Scientific Limited (BOM:512529)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Pharmaceuticals	15.51B	13.70B	14.21B	14.13B	13.62B
Pharmaceuticals Growth	13.26%	-3.60%	0.57%	3.76%	15.47%
Total	15.51B	13.70B	14.21B	14.13B	13.62B
Total Growth	13.26%	-3.60%	0.57%	3.76%	15.47%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Europe	7.00B	5.72B	5.76B	5.94B	6.25B
Europe Growth	22.50%	-0.68%	-3.15%	-4.86%	20.32%
Asia	4.45B	3.30B	4.76B	3.90B	3.89B
Asia Growth	34.78%	-30.70%	22.16%	0.32%	1.62%
Rest of the World	4.06B	4.68B	3.69B	4.29B	3.48B
Rest of the World Growth	-13.20%	26.82%	-13.90%	23.06%	25.45%
Total	15.51B	13.70B	14.21B	14.13B	13.62B
Total Growth	13.26%	-3.60%	0.57%	3.76%	15.47%

Source: S&P Global Market Intelligence.